References
- Ghadi R, Dand N. BCS class IV drugs: highly notorious candidates for formulation development. J Control Release. 2017;248:71–95.
- Zhao JJ, Yang J, Xie Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. Int J Pharm. 2019;570:118642–118663.
- Kouhpeikar H, Butler AE, Bamian F, et al. Curcumin as a therapeutic agent in leukemia. J Cell Physiol. 2019;234(8):12404–12414.
- Li JJ, Chen T, Deng F, et al. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid. Int J Nanomed. 2015;10:5475–5487.
- Wong KE, Ngai SC, Chan KG, et al. Curcumin nanoformulations for colorectal cancer: a review. Front Pharmacol. 2019;10:152–177.
- Yallapu MM, Jaggi M, Chauhan SC. Beta-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 2010;79(1):113–125.
- Hamano N, Bottger R, Lee SE, et al. Robust microfluidic technology and new lipid composition for fabrication of curcumin-loaded liposomes: effect on the anticancer activity and safety of cisplatin. Mol Pharmaceutics. 2019;16(9):3957–3967.
- Sun D, Zhou JK, Zhao LS, et al. Novel curcumin liposome modified with hyaluronan targeting CD44 plays an anti-leukemic role in acute myeloid leukemia in vitro and in vivo. ACS Appl Mater Interfaces. 2017;9(20):16857–16868.
- Esmaili Z, Bayrami S, Dorkoosh FA, et al. Development and characterization of electrosprayed nanoparticles for encapsulation of curcumin. J Biomed Mater Res A. 2018;106(1):285–292.
- Homayouni A, Amini M, Sohrabi M, et al. Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization. Int J Pharm. 2019;562:124–134.
- Hu LD, Jia YH, Niu F, et al. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. J Agric Food Chem. 2012;60(29):7137–7141.
- Li J, Wang X, Li C, et al. Viewing molecular and interface interactions of curcumin amorphous solid dispersions for comprehending dissolution mechanisms. Mol Pharm. 2017;14(8):2781–2792.
- Onoue S, Takahashi H, Kawabata Y, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci. 2010;99(4):1871–1881.
- Kim JY, Kim S, Papp M, et al. Hydrotropic solubilization of poorly water-soluble drugs. J Pharm Sci. 2010;99(9):3953–3965.
- Das S, Paul S. Hydrotropic solubilization of sparingly soluble riboflavin drug molecule in aqueous nicotinamide solution. J Phys Chem B. 2017;121(37):8774–8785.
- Karagianni A, Kachrimanis K, Nikolakakis I. Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery. Pharmaceutics. 2018;10(3):98.
- Li HY, Ma L, Li X, et al. A simple and effective method to improve bioavailability of glimepiride by utilizing hydrotropy technique. Eur J Pharm Sci. 2015;77:154–160.
- Zou SY, Wang XM, Liu P, et al. Arginine metabolism and deprivation in cancer therapy. Biomed Pharmacother. 2019;118:109210–109221.
- Liang HL, Mokrani A, Ji K, et al. Effects of dietary arginine on intestinal antioxidant status and immunity involved in Nrf2 and NF-κB signaling pathway in juvenile blunt snout bream, megalobrama amblycephala. Fish Shellfish Immun. 2018;82:243–249.
- Mcknight JR, Satterfield MC, Jobgen WS, et al. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids. 2010;39(2):349–357.
- Elshaer A, Khan S, Perumal D, et al. Use of amino acids as counterions improves the solubility of the BCS II model drug, indomethacin. Curr Drug Deliv. 2011;8(4):363–372.
- Renny JS, Tomasevich LL, Tallmadge EH, et al. Method of continuous variations: applications of job plots to the study of molecular associations in organometallic chemistry. Angew Chem Int Ed. 2013;52(46):11998–12013.
- Celia C, Scala A, Stancanelli R, et al. Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate. Int J Pharm. 2017;534(1–2):316–324.
- Agrawal S, Pancholi SS, Jain NK, et al. Hydrotropic solubilization of nimesulide for parenteral administration. Int J Pharm. 2004;274(1–2):149–155.
- Ke XY, Tang HY, Mao HQ. Effective encapsulation of curcumin in nanoparticles enabled by hydrogen bonding using flash nanocomplexation. Int J Pharm. 2019;564:273–280.
- Gupta P, Bansal AK. Molecular interactions in celecoxib-PVP-meglumine amorphous system. J Pharm Pharmacol. 2005;57(3):303–310.
- Cui Y, Xing C, Ran Y. Molecular dynamics simulations of hydrotropic solubilization and self-aggregation of nicotinamide. J Pharm Sci. 2010;99(7):3048–3059.
- Booth JJ, Omar M, Abbott S, et al. Hydrotrope accumulation around the drug: the driving force for solubilization and minimum hydrotrope concentration for nicotinamide and urea. Phys Chem Chem Phys. 2015;17(12):8028–8037.
- Shimizu S, Matubayasi N. Hydrotropy: monomer–micelle equilibrium and minimum hydrotrope concentration. J Phys Chem B. 2014;118(35):10515–10524.
- Das S, Paul S. Computer simulation studies of the mechanism of hydrotrope-assisted solubilization of a sparingly soluble drug molecule. J Phys Chem B. 2016;120(14):3540–3550.
- Chantereau G, Sharma M, Abednejad A, et al. Design of nonsteroidal anti-inflammatory drug-based ionic liquids with improved water solubility and drug delivery. ACS Sustainable Chem Eng. 2019;7(16):14126–14134.
- Lee HL, Vasoya JM, Cirqueira MDL, et al. Continuous preparation of 1:1 haloperidol-maleic acid salt by a novel solvent-free method using a twin screw melt extruder. Mol Pharm. 2017;14(4):1278–1291.
- Behbahani ES, Ghaedi M, Abbaspour M, et al. Curcumin loaded nanostructured lipid carriers: in vitro digestion and release studies. Polyhedron. 2019;164:113–122.
- Aloisio C, De Oliveira AG, Longhi MR. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug. Drug Dev Ind Pharm. 2014;40(7):919–928.
- Vakani SS, Kajwe A, Suvarna V, et al. Influence of auxiliary agents on solubility and dissolution profile of repaglinide with hydroxypropyl-β-cyclodextrin: inclusion complex formation and its solid-state characterization. J Incl Phenom Macrocycl Chem. 2015;83(3–4):239–250.
- Sabahi H, Khorami M, Rezayan AH, et al. Surface functionalization of halloysite nanotubes via curcumin inclusion. Colloid Surface A. 2018;538:834–840.
- Wesolowski M, Rojek B. Thermogravimetric detection of incompatibilities between atenolol and excipients using multivariate techniques. J Therm Anal Calorim. 2013;113(1):169–177.
- LoBmann K, Laitinen R, Grohganz H, et al. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Mol Pharm. 2011;8(5):1919–1928.
- Affandi MM, Tripathy M, Majeed AB. Arginine complexes with simvastatin: apparent solubility, in vitro dissolution and solid state characterization. Curr Drug Deliv. 2018;15(1):77–86.
- Dengale SJ, Grohganz H, Rades T, et al. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 2016;100:116–125.
- Lobmann K, Grohganz H, Laitinen R, et al. Amino acids as co-amorphous stabilizers for poorly water soluble drugs-part 1: preparation, stability and dissolution enhancement. Eur J Pharm Biopharm. 2013;85(3):873–881.
- Jensen KT, Lobmann K, Rades T, et al. Improving co-amorphous drug formulations by the addition of the highly water soluble amino acid, proline. Pharmaceutics. 2014;6(3):416–435.